Feed Preview

T Cell Reactivity to Tau & Alpha-Synuclein in PD (MDS)

T Cell Reactivity to Tau & Alpha-Synuclein in PD (MDS) diagram by GerryShaw, Wikimedia
GerryShaw, Wikimedia

Tau and alpha-synuclein are proteins that form aggregates which characterize various neurodegenerative disorders including Parkinson’s disease. This feed focuses on the reaction of T lymphocytes in response to tau and alpha-synuclein.

Top 20 most recent papers

Tau accumulates in Crohn's disease gut

bioRxivMarch 18, 2020
Alice PrigentMalvyne Rolli-Derkinderen
Acta Neuropsychiatrica

Systematic review of gene expression studies in people with Lewy Body Dementia

Acta NeuropsychiatricaMarch 18, 2020
Anisa Chowdhury, Anto P Rajkumar
Brain : a Journal of Neurology

Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson's disease

Brain : a Journal of NeurologyMarch 24, 2020
Yaping ChuJeffrey H Kordower
Nature Reviews. Neurology

Protein transmission in neurodegenerative disease

Nature Reviews. NeurologyMarch 24, 2020
Chao PengVirginia M-Y Lee
Nature Reviews. Molecular Cell Biology

Lipids as the key to understanding α-synuclein behaviour in Parkinson disease

Nature Reviews. Molecular Cell BiologyMarch 24, 2020
Roni Stok, Avraham Ashkenazi
Brain : a Journal of Neurology

Variants in saposin D domain of prosaposin gene linked to Parkinson's disease

Brain : a Journal of NeurologyMarch 24, 2020
Yutaka OjiNobutaka Hattori
International Journal of Molecular Sciences

Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain

International Journal of Molecular SciencesMarch 27, 2020
Yasushi YabukiKohji Fukunaga
European Journal of Medicinal Chemistry

Non-polyphenolic natural inhibitors of amyloid aggregation

European Journal of Medicinal ChemistryMarch 17, 2020
Liang MaKun Huang
Parkinsonism & Related Disorders

Peripheral alpha-synuclein levels in patients with genetic and non-genetic forms of Parkinson's disease

Parkinsonism & Related DisordersApril 3, 2020
Evangelia EmmanouilidouLeonidas Stefanis
Movement Disorders : Official Journal of the Movement Disorder Society

Biofluid Biomarkers in Parkinson's Disease: Clarity Amid Controversy

Movement Disorders : Official Journal of the Movement Disorder SocietyMarch 29, 2020
Sophia R L VieiraAnthony H V Schapira

CNTNAP4 deficiency in dopaminergic neurons initiates parkinsonian phenotypes

TheranosticsMarch 21, 2020
Wenlong ZhangYunlong Zhang

See more papers from this feed

Related Feeds

Allen Institute for Brain Science Network (MDS)

The Allen Institute for Brain Science Network is a not-for-profit biomedical research organization that provides open access to multiple neuroscience tools and resources. Find the latest research from tjr Allen Institute for Brain Science Network here.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alpha-Synuclein Antibody Therapeutics (MDS)

Alpha-synuclein is an integral component of Lewy bodies which are comprised of protein clumps and are a pathological hallmark of Parkinson’s disease. They have also been detected in several other neurodegenerative diseases, known as synucleopathies. Here is the latest research on alpha-synuclein antibody therapeutics.

Astrocytes & Huntington’s Disease (MDS)

Astrocytes are abundant within the central nervous system and their dysfunction has been thought to be an important contributor to some neurodegenerative diseases, in particular Huntington’s disease. Damage to these cells may make neurons more susceptible to degeneration. Here is the latest research on astrocytes and Huntington’s disease.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Atypical Parkinsonism (MDS)

Atypical Parkinsonism presents with the same signs and symptoms of Parkinson's disease, but do not respond to typical Parkionson's disease treatment with levodopa. Atypical Parkinsonism is thought to be associated with abnormal protein buildup within brain cells. Here is the latest on Atypical Parkinsonism.

Autophagy: Cancer & Parkinson (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in cancer and Parkinson’s.

BRAIN Initiative Cell Census Network (MDS)

The BRAIN Initiative Cell Census Network aims to identify and provide experimental access to the different brain cell types to determine their roles in health and disease. Discover the latest research from researchers in the BRAIN Initiative Cell Census Network here.

Basal ganglia in Parkinson's disease (MDS)

The basal ganglia is comprised of the neostriatum, the external and internal pallidal segments, the subthalamic nucleus, the substantia nigra pars reticulata, and the pars compacta of the substantia nigra. The basal ganglia circuitry is responsible for the correct execution of voluntary movements and is implicated in Parkinson's disease. Here is the latest research investigating the basal ganglia in Parkinson's disease.

© 2020 Meta ULC. All rights reserved